Type 2 Diabetes Blood Test Monitoring

Type 2 diabetes is one of the most significant public health challenges facing the United Kingdom. There are currently 4.3 million people in the UK living with a diabetes diagnosis, the vast majority of whom have type 2. An estimated 850,000 more are living with undiagnosed type 2 diabetes, and a further 13.6 million people are at increased risk of developing the condition. The financial burden on the NHS is enormous — diabetes accounts for approximately 10% of the entire NHS budget.

Whether you have been recently diagnosed, have been managing type 2 diabetes for years, or have been told you are pre-diabetic, regular blood test monitoring is the cornerstone of effective management. But diabetes monitoring goes far beyond checking your blood sugar. The complications of type 2 diabetes — cardiovascular disease, kidney damage, liver disease, nerve damage — are what drive the serious health consequences. Monitoring the right blood markers is how you stay ahead of them.

HbA1c: The Gold Standard

HbA1c (glycated haemoglobin) measures the percentage of your haemoglobin that has glucose attached to it. Because red blood cells live for approximately 120 days, HbA1c provides an average picture of your blood sugar control over the preceding 2–3 months. It is far more informative than a single fasting glucose reading, which only captures a snapshot.

The diagnostic thresholds are clearly defined:

• Below 42 mmol/mol: Normal
• 42–47 mmol/mol: Pre-diabetes (also called non-diabetic hyperglycaemia)
• 48 mmol/mol or above: Diabetes

For people already diagnosed with type 2 diabetes, NICE guidelines recommend an HbA1c target of 48 mmol/mol if managed by diet and lifestyle alone, or 53 mmol/mol if taking a single medication such as metformin. Targets may be individualised — for example, tighter control is generally recommended for younger patients, while slightly more relaxed targets may be appropriate for elderly patients with multiple comorbidities.

The relationship between HbA1c and complications is well established. The UK Prospective Diabetes Study (UKPDS) demonstrated that every 1% reduction in HbA1c was associated with a 21% reduction in diabetes-related deaths, a 14% reduction in heart attacks, and a 37% reduction in microvascular complications.

Beyond Sugar: Cardiovascular Risk Markers

Cardiovascular disease is the number one cause of death in people with type 2 diabetes. The risk of heart attack or stroke is approximately two to four times higher than in the general population. This makes cardiovascular monitoring not optional but essential.

Lipid Panel

People with type 2 diabetes commonly develop a characteristic pattern of dyslipidaemia: elevated triglycerides, low HDL cholesterol, and an increased number of small dense LDL particles (which are particularly atherogenic). A standard lipid panel should include total cholesterol, LDL cholesterol, HDL cholesterol, non-HDL cholesterol, and triglycerides. NICE recommends offering statin therapy to all adults with type 2 diabetes, with a target of at least 40% reduction in non-HDL cholesterol.

High-Sensitivity C-Reactive Protein (hs-CRP)

hs-CRP is a marker of systemic inflammation and an independent predictor of cardiovascular events. In people with type 2 diabetes, elevated hs-CRP (above 3 mg/L) indicates heightened inflammatory and cardiovascular risk. It adds prognostic information beyond what cholesterol alone provides.

Kidney Function: Catching Diabetic Nephropathy Early

Diabetic kidney disease (diabetic nephropathy) is the leading cause of end-stage renal disease in the UK. It develops silently over years, which is precisely why regular monitoring is so important.

The two key markers are:

• eGFR (estimated Glomerular Filtration Rate): Calculated from your creatinine level, age, and sex. An eGFR above 90 mL/min is normal. A sustained eGFR below 60 mL/min indicates chronic kidney disease stage 3 or worse. In diabetes, a declining eGFR trend — even within the normal range — warrants attention.
• Urine Albumin-to-Creatinine Ratio (uACR): This detects microalbuminuria, the earliest sign of diabetic kidney damage. A result above 3 mg/mmol is abnormal. NICE recommends annual uACR testing for all people with diabetes.

Blood-based markers of kidney function include creatinine, urea, and electrolytes (sodium, potassium, chloride, bicarbonate). These are included in standard kidney function panels and help monitor the progression of any kidney impairment.

Liver Function: The NAFLD Connection

Non-alcoholic fatty liver disease (NAFLD) is present in over 70% of people with type 2 diabetes. The relationship is bidirectional — insulin resistance drives fat accumulation in the liver, and fatty liver worsens insulin resistance. In a significant minority of cases, NAFLD progresses to non-alcoholic steatohepatitis (NASH), fibrosis, and eventually cirrhosis.

Key liver markers to monitor include:

• ALT (Alanine Transaminase): The most sensitive marker for liver cell damage. In people with type 2 diabetes, even mildly elevated ALT (above 30 U/L for men, above 19 U/L for women according to revised thresholds proposed by some hepatologists) warrants investigation for fatty liver disease.
• GGT (Gamma-Glutamyl Transferase): Elevated in metabolic liver disease and a strong predictor of both liver outcomes and cardiovascular risk in diabetes.
• AST (Aspartate Transaminase): An AST:ALT ratio greater than 1 may suggest more advanced liver disease (fibrosis or cirrhosis).

Full Blood Count

A full blood count (FBC) provides information that is relevant to diabetes management in several ways. Haemoglobin levels are important because anaemia — particularly common in diabetes due to kidney disease — can falsely lower HbA1c results, giving a misleadingly optimistic picture of glucose control. Mean corpuscular volume (MCV) may be elevated in B12 deficiency, which is specifically relevant for patients on metformin.

Vitamin B12: The Metformin Connection

Metformin is the first-line medication for type 2 diabetes and is taken by millions of people in the UK. What is less well known is that metformin reduces vitamin B12 absorption in 10–30% of long-term users. The mechanism involves interference with the calcium-dependent uptake of the B12-intrinsic factor complex in the terminal ileum.

B12 deficiency causes fatigue, peripheral neuropathy (tingling, numbness, pain in the hands and feet), cognitive difficulties, and macrocytic anaemia. The neuropathy symptoms are particularly problematic because they can be mistakenly attributed to diabetic neuropathy, leading to the true cause being missed. NICE guidelines now recommend considering annual B12 monitoring for patients on long-term metformin.

Vitamin D

Vitamin D deficiency is more prevalent in people with type 2 diabetes than in the general population. Evidence suggests that vitamin D plays a role in insulin secretion and insulin sensitivity. A large meta-analysis published in Diabetes Care found that vitamin D supplementation in people with pre-diabetes reduced the risk of progression to type 2 diabetes. For those already diagnosed, maintaining adequate vitamin D levels (above 75 nmol/L) supports metabolic health and immune function.

How Often Should You Test?

NICE recommends HbA1c testing every 3–6 months for people with type 2 diabetes, depending on how stable their control is. An annual review should include a full lipid panel, kidney function, liver function, and a full blood count. However, these annual NHS reviews are often limited in scope and can be delayed due to capacity constraints. Private blood testing allows you to monitor at the frequency that suits your clinical needs rather than waiting for an appointment.

Testing Options at Lola Health

Our Cardiovascular Health test (£83) includes HbA1c, a full lipid panel, and high-sensitivity CRP — the key markers for monitoring glucose control and the cardiovascular risk that accompanies diabetes. For broader monitoring including liver function, kidney function, full blood count, and vitamins, our Core Health 45 test (£120) provides 45 biomarkers in a single panel, covering all the diabetes monitoring essentials discussed in this article.

Key Takeaways

• HbA1c is the gold standard for glucose monitoring: below 42 normal, 42–47 pre-diabetes, 48+ diabetes.
• Cardiovascular disease is the leading cause of death in type 2 diabetes — monitor lipids and hs-CRP alongside HbA1c.
• Kidney function (eGFR, creatinine) should be checked regularly — diabetic nephropathy is silent until advanced.
• Over 70% of people with type 2 diabetes have fatty liver disease — liver function tests (ALT, GGT) are essential.
• Long-term metformin use depletes B12 in up to 30% of patients — annual monitoring is recommended.
• Comprehensive blood testing catches complications early, when intervention is most effective.

Managing type 2 diabetes effectively means looking beyond blood sugar. The complications that drive serious health outcomes — heart disease, kidney damage, liver disease, neuropathy — are preventable and manageable, but only if you are monitoring for them. Regular, comprehensive blood testing is the most powerful tool you have.